Investing in
neurotransformational medicines

Provide evidence

Ceruvia continues to generate data from controlled clinical trials in top medical schools and commercial settings.
We fund and work with innovative collaborators and partners to discover and develop promising medicines to treat challenging disorders.
Ceruvia Lifesciences is built on sound science and has gathered key, experienced consultants and scientific advisors to advance projects.


We are the world’s first producers of GMP LSD, and GMP BOL-148. We adhere to the highest development, testing, and manufacturing standards as established by regulatory authorities as well as pharmaceutical industry associations and organizations.


We envision a future where Ceruvia Lifesciences can deploy treatments to create a significant benefit for all stakeholders in our focus areas: patients, caregivers, payers, and health care providers and investors.


Stay informed of Ceruvia news and research

Please enter Your Email

Skip to content